Identification of New IκBα Complexes by an Iterative Experimental and Mathematical Modeling Approach

The transcription factor nuclear factor kappa-B (NFκB) is a key regulator of pro-inflammatory and pro-proliferative processes. Accordingly, uncontrolled NFκB activity may contribute to the development of severe diseases when the regulatory system is impaired. Since NFκB can be triggered by a huge variety of inflammatory, pro-and anti-apoptotic stimuli, its activation underlies a complex and tightly regulated signaling network that also includes multi-layered negative feedback mechanisms. Detailed understanding of this complex signaling network is mandatory to identify sensitive parameters that may serve as targets for therapeutic interventions. While many details about canonical and non-canonical NFκB activation have been investigated, less is known about cellular IκBα pools that may tune the cellular NFκB levels. IκBα has so far exclusively been described to exist in two different forms within the cell: stably bound to NFκB or, very transiently, as unbound protein. We created a detailed mathematical model to quantitatively capture and analyze the time-resolved network behavior. By iterative refinement with numerous biological experiments, we yielded a highly identifiable model with superior predictive power which led to the hypothesis of an NFκB-lacking IκBα complex that contains stabilizing IKK subunits. We provide evidence that other but canonical pathways exist that may affect the cellular IκBα status. This additional IκBα:IKKγ complex revealed may serve as storage for the inhibitor to antagonize undesired NFκB activation under physiological and pathophysiological conditions.

[1]  Oliver Sawodny,et al.  Mechanism of PP2A-mediated IKKβ dephosphorylation: a systems biological approach , 2009, BMC Systems Biology.

[2]  Marek Kimmel,et al.  Mathematical model of NF- κB regulatory module , 2004 .

[3]  G. Casari,et al.  A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. , 2004, Nature cell biology.

[4]  Pascal Meier,et al.  IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer , 2010, Nature Reviews Cancer.

[5]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[6]  Henning Walczak,et al.  No one can whistle a symphony alone – how different ubiquitin linkages cooperate to orchestrate NF-κB activity , 2012, Journal of Cell Science.

[7]  S. Shumway,et al.  Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells. , 2004, Molecular and cellular biology.

[8]  Ramin Massoumi,et al.  CYLD: a deubiquitination enzyme with multiple roles in cancer. , 2011, Future oncology.

[9]  N. Kudo,et al.  A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Horvitz,et al.  Phosphorylation of IκB-α Inhibits Its Cleavage by Caspase CPP32 in Vitro * , 1997, The Journal of Biological Chemistry.

[11]  Fei Chen,et al.  Calpain Contributes to Silica-Induced IκB-α Degradation and Nuclear Factor-κB Activation , 1997 .

[12]  R. Roeder,et al.  The role of general initiation factors in transcription by RNA polymerase II. , 1996, Trends in biochemical sciences.

[13]  Andreas Untergasser,et al.  Preclinical Differentiation between Apparently Safe and Potentially Hepatotoxic Applications of TRAIL Either Alone or in Combination with Chemotherapeutic Drugs , 2006, Clinical Cancer Research.

[14]  S. Shumway,et al.  A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells. , 2004, The Biochemical journal.

[15]  M. Karin,et al.  Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. , 1999, Science.

[16]  Andre Levchenko,et al.  A homeostatic model of IκB metabolism to control constitutive NF-κB activity , 2007, Molecular systems biology.

[17]  Alexander Hoffmann,et al.  IκBɛ provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression , 2006, The Journal of cell biology.

[18]  Andre Levchenko,et al.  Transient IκB Kinase Activity Mediates Temporal NF-κB Dynamics in Response to a Wide Range of Tumor Necrosis Factor-α Doses* , 2006, Journal of Biological Chemistry.

[19]  David S. Broomhead,et al.  Sensitivity analysis of parameters controlling oscillatory signalling in the NF-/sub K/Bpathway: the roles of IKK and I/sub K/B/sub alpha/ , 2004 .

[20]  Vinay Tergaonkar,et al.  Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential. , 2009, Clinical science.

[21]  D. S. Broomhead,et al.  Pulsatile Stimulation Determines Timing and Specificity of NF-κB-Dependent Transcription , 2009, Science.

[22]  Eva E. Qwarnstrom,et al.  Dynamic Shuttling of Nuclear Factor κB between the Nucleus and Cytoplasm as a Consequence of Inhibitor Dissociation* , 2000, The Journal of Biological Chemistry.

[23]  Minoru Yoshida,et al.  A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes , 2000 .

[24]  B. Aggarwal,et al.  Nuclear factor-kappaB: the enemy within. , 2004, Cancer cell.

[25]  Alexander Hoffmann,et al.  IκBε provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression , 2006 .

[26]  F. D. Di Padova,et al.  All three IkappaB isoforms and most Rel family members are stably associated with the IkappaB kinase 1/2 complex. , 1999, European journal of biochemistry.

[27]  F. Yoshimura,et al.  Genistein reduces NF-kappa B in T lymphoma cells via a caspase-mediated cleavage of I kappa B alpha. , 2003, Biochemical pharmacology.

[28]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[29]  Alexander Hoffmann,et al.  Understanding the temporal codes of intra-cellular signals. , 2010, Current opinion in genetics & development.

[30]  Jens Timmer,et al.  Dynamical modeling and multi-experiment fitting with PottersWheel , 2008, Bioinform..

[31]  Alexander Hoffmann,et al.  UV as an amplifier rather than inducer of NF-kappaB activity. , 2008, Molecular cell.

[32]  Alexander Hoffmann,et al.  Lessons from mathematically modeling the NF‐κB pathway , 2012, Immunological reviews.

[33]  J. Tschopp,et al.  TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. , 1997, Immunity.

[34]  V. Dixit,et al.  Regulation of NF‐κB by deubiquitinases , 2012, Immunological reviews.

[35]  F. Chen,et al.  Calpain contributes to silica-induced I kappa B-alpha degradation and nuclear factor-kappa B activation. , 1997, Archives of biochemistry and biophysics.

[36]  Marek Kimmel,et al.  Mathematical model of NF-kappaB regulatory module. , 2004, Journal of theoretical biology.

[37]  S. Shumway,et al.  Regulation of Constitutive p50/c-Rel Activity via Proteasome Inhibitor-Resistant IκBα Degradation in B Cells , 2004, Molecular and Cellular Biology.

[38]  Oliver Sawodny,et al.  Analysing the Role of UVB-Induced Translational Inhibition and PP2Ac Deactivation in NF-κB Signalling Using a Minimal Mathematical Model , 2012, PloS one.

[39]  Timothy W. Sikorski,et al.  The basal initiation machinery: beyond the general transcription factors. , 2009, Current opinion in cell biology.

[40]  H. Walczak,et al.  Identification of PP2A as a crucial regulator of the NF-κB feedback loop: its inhibition by UVB turns NF-κB into a pro-apoptotic factor , 2008, Cell Death and Differentiation.

[41]  Felix Freuler,et al.  All three IκB isoforms and most Rel family members are stably associated with the IκB kinase 1/2 complex , 1999 .

[42]  Kenji Konaka,et al.  Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha. , 2004, The Journal of biological chemistry.

[43]  Sandra Barisic,et al.  Tyrosine phosphatase inhibition triggers sustained canonical serine-dependent NFkappaB activation via Src-dependent blockade of PP2A. , 2010, Biochemical pharmacology.

[44]  Andre Levchenko,et al.  Transient IkappaB kinase activity mediates temporal NF-kappaB dynamics in response to a wide range of tumor necrosis factor-alpha doses. , 2006, The Journal of biological chemistry.

[45]  Alexander Hoffmann,et al.  Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity , 2005, Science.

[46]  H. Horvitz,et al.  Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro. , 1997, The Journal of biological chemistry.

[47]  D. Kulms,et al.  Differential effects of NF-κB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome , 2006, Oncogene.

[48]  N. Rice,et al.  In vivo control of NF‐kappa B activation by I kappa B alpha. , 1993, The EMBO journal.

[49]  F. Yoshimura,et al.  Genistein reduces NF-κB in T lymphoma cells via a caspase-mediated cleavage of IκBα , 2003 .

[50]  Michael Karin,et al.  Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .

[51]  Kenji Konaka,et al.  Fas Ligand Induces Cell-autonomous NF-κB Activation and Interleukin-8 Production by a Mechanism Distinct from That of Tumor Necrosis Factor-α* , 2004, Journal of Biological Chemistry.

[52]  Inder M Verma,et al.  NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.

[53]  Dagmar Kulms,et al.  NFκB-dependent Down-regulation of Tumor Necrosis Factor Receptor-associated Proteins Contributes to Interleukin-1-mediated Enhancement of Ultraviolet B-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[54]  D. Broomhead,et al.  Sensitivity analysis of parameters controlling oscillatory signalling in the NFk B pathway : the roles of IKK and I k B a , 2004 .